4.5 Article

Genetic testing in familial and young-onset Alzheimer's disease: mutation spectrum in a Serbian cohort

期刊

NEUROBIOLOGY OF AGING
卷 33, 期 7, 页码 -

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2011.12.007

关键词

Alzheimer's disease; Mutations; Serbia; Presenilins; APP

资金

  1. MRC [G0701075] Funding Source: UKRI
  2. Alzheimers Research UK [ART-PG2010-1, ART-PPG2011A-14] Funding Source: researchfish
  3. Medical Research Council [G0701075] Funding Source: researchfish
  4. Medical Research Council [G0701075] Funding Source: Medline

向作者/读者索取更多资源

Alzheimer's disease (AD) is the most common form of dementia. To date, more than 200 mutations in three genes have been identified as cause of early-onset autosomal dominant inherited AD. The aim of this study was to characterize the mutation spectrum and describe genotype-phenotype correlations in Serbian patients with positive family history of AD or/and early-onset AD. We performed a genetic screening for mutations in the coding regions of Presenilins 1 and 2 (PSEN1 and PSEN2), as well as exons 16 and 17 of the Amyloid Precursor Protein gene (APP) in a total of 47 patients from Serbia with a clinical diagnosis of familial and/or early-onset AD (mean age at onset of 60.3 years; range 32-77). We found one novel mutation in PSEN1, one novel variant in PSEN2, and three previously described variants, one in each of the analyzed genes. Interestingly, we identified one patient harboring two heterozygous mutations: one in APP (p.L723P) and one in PSEN1 (p.R108Q). (C) 2012 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据